November - 2015

top of page

Richmond Times-Dispatch Article about NEXT Molecular Analytics

Richmond Times-Dispatch Article about NEXT Molecular Analytics

Richmond Times-Dispatch Article about NEXT Molecular Analytics

NEXT Molecular Analytics article in the business section of the Richmond Times-Dispatch.

NEXT to Present Keynote Presentation on Precision Medicine

NEXT to Present Keynote Presentation on Precision Medicine

NEXT to Present Keynote Presentation on Precision Medicine

NEXT Bio-Research Service’s CMO and Laboratory Director, Dai “Dave” J. Li, MD, MSc., Ph.D., FACB to present Keynote presentation on...

NEXT BIO-RESEARCH SERVICES LLC BEGINS OPERATIONS

NEXT BIO-RESEARCH SERVICES LLC BEGINS OPERATIONS

NEXT BIO-RESEARCH SERVICES LLC BEGINS OPERATIONS

NEXT BIO-RESEARCH SERVICES LLC BEGINS OPERATIONS Company Offers Esoteric Clinical Tests and Fundamental Research in the Life Sciences...

Featured Posts

Check back soon

Once posts are published, you’ll see them here.

Recent Posts

NEXT Scientist publishes paper: Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions

NEXT Scientist publishes paper: Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions

NEXT Scientist publishes paper: Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions

L-asparaginase chemotherapy is integral in the treatment of pediatric, adolescent, and young adult (AYA) patients with Acute Lymphoblastic Leukemia (ALL). Its incorporation, as part of a multi-agent c

L-asparaginase chemotherapy is integral in the treatment of pediatric, adolescent, and young adult (AYA) patients with Acute Lymphoblastic Leukemia (ALL). Its incorporation, as part of a multi-agent c

L-asparaginase chemotherapy is integral in the treatment of pediatric, adolescent, and young adult (AYA) patients with Acute Lymphoblastic Leukemia (ALL). Its incorporation, as part of a multi-agent c

NEXT Scientists contribute to paper on pharmacogenomics of CYP450 genes

CiRT Receives Clinical Approval from NYSHD CLEP

NEXT Molecular Analytics Receives Accreditation from the New York State Department of Health for its L-Asparaginase Enzyme Activity Assay Platform

Oxford BioDynamics announces US launch of its Checkpoint Inhibitor Response Test (EpiSwitch® CiRT) foroncology

Richmond Times-Dispatch Article about NEXT Molecular Analytics

NEXT to Present Keynote Presentation on Precision Medicine

NEXT BIO-RESEARCH SERVICES LLC BEGINS OPERATIONS

Archive

Search By Tags

Follow Us

bottom of page